HIV, aids, depression depressie, somberheid
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Being HIV positive. - The presence of mild to moderate depressive symptoms (defined as PHQ-9 score >4 and < 20). - Age 18 and older. - Sufficient knowledge of the Dutch or English language. - Access to the Internet. - Having an e-mail address. - Available for the next 8 weeks to work on the intervention.
Exclusion criteria
Exclusion criteria: - Being in the first half year post HIV-diagnosis. - Having severe cognitive impairments (e.g. forgetfulness). - The presence of severe depressive symptoms (defined as PHQ-9 score of 20 or higher). - Prominent suicide ideation (indicated by a score >1 on the suicide item of the PHQ-9). - The absence of depressive symptoms (indicated by a PHQ-9 score of 4 or lower). - Treatment by a psychologist or psychiatrist at the moment. - Use of antidepressants for less than 3 months or change of type or dose of antidepressants in the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depressive symptoms: Patient Health Questionnaire 9 (PHQ-9) and the Center of Epidemiologic Studies Depression Scale (CES-D). Timepoint: pretest, end of intervention/waiting period and 3 and 6 months later. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are: physical tension; activation (Behavioral Activation for Depression Scale [BADS]); cognitive reappraisal (Emotion Regulation Questionnaire [ERQ]); cognitive coping (Cognitive Emotion Regulation Questionnaire [CERQ]); depressive thoughts (Crandell Cognitions Inventory [CCI]); behavioral coping (Behavioral Emotion Regulation Questionnaire [BERQ]); coping self-efficacy; goal adjustment (Goal Disengagement and Reengagement Scale); personal growth; symptoms of anxiety (Generalized Anxiety Disorder 7 [GAD-7]); negative life events (Life Events Scale); motivation to start with the intervention; compliance; dropout and reasons for dropout; medical data; and user satisfaction. Secondary outcomes will be measures at the pretest and at the 3 posttests. As potential moderators of treatment outcome demographic variables (such as gender and age), clinical and psychological characteristics (such as severity of depressive symptoms at baseline) will be tested. Mediator variables and the dependent variable will be measured three times during the intervention/waiting period, at the pretest and the first posttest. The following mediator variables will be assessed in the study: activation (2 items of the BADS), physical tension (2 items), cognitive reappraisal (2 items of the ERQ), cognitive coping (12 items of the CERQ), goal adjustment (2 items of the Goal disengagement and Reengagement Scale), symptoms of anxiety (PHQ-4), and self-efficacy (2 items). The dependent variable in the mediational analysis is depressive symptoms (PHQ-4). | — |
Contacts
Leiden University, Faculty of Social Sciences, Clinical Psychology